✦ LIBER ✦

Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study

✍ Scribed by Chi-Leung Liu; Sheung-Tat Fan; Irene Oi-Lin Ng; Chung-Mau Lo; Ronnie Tung-Ping Poon; John Wong

Book ID: 119396870
Publisher: Nature Publishing Group
Year: 2000
Tongue: English
Weight: 49 KB
Volume: 95
Category: Article
ISSN: 0002-9270
DOI: 10.1016/s0002-9270(99)00747-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective and randomized controlled st

Prospective and randomized controlled study of chemoembolization therapy in patients with advanced hepatocellular carcinoma

✍ Seishiro Watanabe, Mikio Nishioka, Yasuyuki Ohta… 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 326 KB

Treatment of advanced hepatocellular car

Treatment of advanced hepatocellular carcinoma (HCC) with tamoxifen (TMX). Preliminary results of a randomized double-blind placebo-controlled trial

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Regression of a Hepatocellular Carcinoma

Regression of a Hepatocellular Carcinoma Following Treatment with Octreotide and Tamoxifen in a Patient with Advanced Alcoholic Cirrhosis

✍ Hakan Senturk; Billur Canbakan; Rana Cumali 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 326 KB

Tissue expression of squamous cellular c

Tissue expression of squamous cellular carcinoma antigen and Ki67 in hepatocellular carcinoma-correlation with prognosis: A historical prospective study

✍ Hemda Schmilovitz-Weiss; Ana Tobar; Marisa Halpern; Izhar Levy; Esther Shabtai; 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 397 KB

Treatment of hepatocellular carcinoma wi

Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: A randomized, controlled trial

✍ Emanuel K. Manesis; Gregory Giannoulis; Pavlos Zoumboulis; Irini Vafiadou; Steph 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 961 KB

We tested the hypothesis that a combination of sex hormone suppression and inhibition of their target receptors might improve survival for patients with hepatocellular carcinoma (HCC). Eighty-five consequent, previously untreated HCC patients with inoperable disease, were randomized to receive the l

A randomized placebo-controlled study of

A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma

✍ Man-Fung Yuen; Ronnie Tung-Ping Poon; Ching-Lung Lai; Sheung-Tat Fan; Chung-Mau 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB